Technical Analysis for VIE - Viela Bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Up |
| Historical VIE trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | -53.00% | |
| Volume Surge | Other | -53.00% | |
| Calm After Storm | Range Contraction | -53.00% | |
| Narrow Range Bar | Range Contraction | -53.00% | |
| NR7 | Range Contraction | -53.00% | |
| NR7-2 | Range Contraction | -53.00% | |
| Crossed Above 200 DMA | Bullish | -52.92% | |
| Crossed Above 20 DMA | Bullish | -52.92% | |
| Crossed Above 50 DMA | Bullish | -52.92% | |
| MACD Bullish Centerline Cross | Bullish | -52.92% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/01/2021
Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immune System Monoclonal Antibody Monoclonal Antibodies Inflammatory Disease Inflammatory Diseases Autoimmune And Inflammatory Diseases Autoimmune And Inflammatory Disease CD19 Monoclonal Antibody Therapy Humanized Antibody Tolerx
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immune System Monoclonal Antibody Monoclonal Antibodies Inflammatory Disease Inflammatory Diseases Autoimmune And Inflammatory Diseases Autoimmune And Inflammatory Disease CD19 Monoclonal Antibody Therapy Humanized Antibody Tolerx
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 64.9999 |
| 52 Week Low | 21.3 |
| Average Volume | 1,500,867 |
| 200-Day Moving Average | 37.49 |
| 50-Day Moving Average | 41.82 |
| 20-Day Moving Average | 30.26 |
| 10-Day Moving Average | 22.82 |
| Average True Range | 1.44 |
| ADX | 65.05 |
| +DI | 22.99 |
| -DI | 59.15 |
| Chandelier Exit (Long, 3 ATRs ) | 48.73 |
| Chandelier Exit (Short, 3 ATRs ) | 25.63 |
| Upper Bollinger Band | 56.57 |
| Lower Bollinger Band | 3.94 |
| Percent B (%b) | 0.4 |
| BandWidth | 173.93 |
| MACD Line | -6.19 |
| MACD Signal Line | -6.50 |
| MACD Histogram | 0.3116 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 25.84 | ||||
| Resistance 3 (R3) | 25.81 | 25.45 | 25.67 | ||
| Resistance 2 (R2) | 25.45 | 25.21 | 25.47 | 25.62 | |
| Resistance 1 (R1) | 25.16 | 25.05 | 25.31 | 25.19 | 25.56 |
| Pivot Point | 24.80 | 24.80 | 24.88 | 24.82 | 24.80 |
| Support 1 (S1) | 24.51 | 24.56 | 24.66 | 24.54 | 24.16 |
| Support 2 (S2) | 24.15 | 24.40 | 24.17 | 24.10 | |
| Support 3 (S3) | 23.86 | 24.15 | 24.05 | ||
| Support 4 (S4) | 23.89 |
